These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 31831046)

  • 1. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
    Androuin A; Potier B; Nägerl UV; Cattaert D; Danglot L; Thierry M; Youssef I; Triller A; Duyckaerts C; El Hachimi KH; Dutar P; Delatour B; Marty S
    Acta Neuropathol; 2018 Jun; 135(6):839-854. PubMed ID: 29696365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease.
    Fu AK; Hung KW; Huang H; Gu S; Shen Y; Cheng EY; Ip FC; Huang X; Fu WY; Ip NY
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9959-64. PubMed ID: 24958880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.
    Pedrazzoli M; Losurdo M; Paolone G; Medelin M; Jaupaj L; Cisterna B; Slanzi A; Malatesta M; Coco S; Buffelli M
    Neurobiol Dis; 2019 Dec; 132():104568. PubMed ID: 31394203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers.
    Vargas LM; Leal N; Estrada LD; González A; Serrano F; Araya K; Gysling K; Inestrosa NC; Pasquale EB; Alvarez AR
    PLoS One; 2014; 9(3):e92309. PubMed ID: 24658113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer's Disease Mice.
    Ma J; Gao Y; Tang W; Huang W; Tang Y
    Curr Alzheimer Res; 2020; 17(1):93-103. PubMed ID: 32053075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.
    Song JM; DiBattista AM; Sung YM; Ahn JM; Turner RS; Yang J; Pak DT; Lee HK; Hoe HS
    Exp Neurol; 2014 Feb; 252():105-13. PubMed ID: 24316432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
    Hollnagel JO; Elzoheiry S; Gorgas K; Kins S; Beretta CA; Kirsch J; Kuhse J; Kann O; Kiss E
    PLoS One; 2019; 14(1):e0209228. PubMed ID: 30645585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
    Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
    J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.
    Lee S; Salazar SV; Cox TO; Strittmatter SM
    J Neurosci; 2019 Mar; 39(10):1910-1929. PubMed ID: 30626696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
    Maiti P; Bowers Z; Bourcier-Schultz A; Morse J; Dunbar GL
    Alzheimers Res Ther; 2021 Feb; 13(1):37. PubMed ID: 33557949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of Na
    Moriguchi S; Kita S; Fukaya M; Osanai M; Inagaki R; Sasaki Y; Izumi H; Horie K; Takeda J; Saito T; Sakagami H; Saido TC; Iwamoto T; Fukunaga K
    Neuropharmacology; 2018 Mar; 131():291-303. PubMed ID: 29274751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Layer-specific alterations to CA1 dendritic spines in a mouse model of Alzheimer's disease.
    Merino-Serrais P; Knafo S; Alonso-Nanclares L; Fernaud-Espinosa I; DeFelipe J
    Hippocampus; 2011 Oct; 21(10):1037-44. PubMed ID: 20848609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.
    Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM
    Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
    Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
    Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.